NEWS CONTACT US CAREERS GET E-MAIL ALERTS SEARCH Home About Us Our Products Our Pipeline Immunotechnology Plasma & IVIG Medical Affairs Investors Investor Relations Overview Press Releases Company Info Analyst Coverage Events & Webcasts Financial Info Stock Info SEC Filings Governance HOME INVESTORS Company Profile ADMA Biologics is an end-to-end commercial biopharmaceutical company committed to manufacturing, marketing and developing specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for infection. Our devotion to these underserved populations fuels us, and our hands-on approach to production and development sets us apart. View Our Latest Corporate Presentation Fiscal Year 2020 Report Download Report Latest News Nov 17, 2021 7:00am EST ADMA Biologics Senior Vice President of Plasma Services Cyndi Tolman Elected to PPTA Source Board of Directors Read Press Release Subscribe to RSS Feed Latest Event Nov 10, 2021 4:30 pm EST ADMA Biologics 3Q 2021 Earnings Call View All Events Latest Financial Results Q3 2021 Quarter Ended Sep 30, 2021 Earnings Release PDF HTML AUDIO Earnings Webcast 10-Q Filing PDF HTML XBRL ZIP XLS HTML About Us Our Products Our Pipeline Inmunotechnology Plasma & IVIG Medical Affairs Investors Privacy Policy Disclaimer Sitemap Contact Us Connect with Us Email Alerts RSS © Copyright 2021 ADMA Biologics, Inc. Ramsey, NJ Offices 201-478-5552 Boca Raton, FL Offices 561-989-5800 info@admabio.com 2020 INNOVATOR AWARD NAMED 2019 COMPANY OF THE YEAR Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.